BIOMARIN PHARMACEUTICAL INC (BMRN) Net Cash Provided by (Used in) Financing Activities USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2024.
  • Biomarin Pharmaceutical Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$42.8 M, a 5.03% decline year-over-year.
  • Biomarin Pharmaceutical Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$18.7 M, a 0.41% decline from 2022.
  • Biomarin Pharmaceutical Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$18.7 M, a 38754% decline from 2021.
  • Biomarin Pharmaceutical Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$48 K, a 100% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$42.8 M -$2.05 M -5.03% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q1 2023 -$40.7 M -$15.5 M -61.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q1 2022 -$25.3 M -$916 K -3.76% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q1 2021 -$24.4 M -$4.69 M -23.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q1 2020 -$19.7 M +$5.31 M +21.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q1 2019 -$25 M -$15.2 M -156% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q1 2018 -$9.77 M Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q1 2014 $137 M +$123 M +891% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-02
Q1 2013 $13.8 M +$375 K +2.79% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q1 2012 $13.4 M +$10.2 M +316% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-29
Q1 2011 $3.23 M -$5.91 M -64.6% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-30
Q1 2010 $9.14 M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.